The development of a high-throughput acoustic droplet ejection mass-spectrometry assay and a solid-supported membrane (SSM)-based electrophysiological assay to study the pharmacological inhibition of SLC1-A3, -A2 and -A1 in a drug discovery program
Authors
Felix Bärenz (ORCID: https://orcid.org/0000-0002-3868-313X)
The development of a high-throughput acoustic droplet ejection mass-spectrometry assay and a solid-supported membrane (SSM)-based electrophysiological assay to study the pharmacological inhibition of SLC1-A3, -A2 and -A1 in a drug discovery program
Felix Bärenz, Thomas Licher, Antje Pommereau, Yasmin Zuschlag et al.
Citations
2 citations
Journal
Frontiers in Pharmacology
Topics
Analytical Chemistry and Chromatography
Field-Weighted Citation Impact (FWCI)
1.51
article
The development of a high-throughput acoustic droplet ejection mass-spectrometry assay and a solid-supported membrane (SSM)-based electrophysiological assay to study the pharmacological inhibition of SLC1-A3, -A2 and -A1 in a drug discovery program
Felix Bärenz, Thomas Licher, Antje Pommereau, Yasmin Zuschlag, Jennifer Warkentin
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
The development of a high-throughput acoustic droplet ejection mass-spectrometry assay and a solid-supported membrane (SSM)-based electrophysiological assay to study the pharmacological inhibition of SLC1-A3, -A2 and -A1 in a drug discovery program — Felix Bärenz, Thomas Licher, et al. · Frontiers in Pharmacology (2025) | TGRS Research Map | TGRS